Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes

Brain Res. 1987 Dec 15;436(2):234-9. doi: 10.1016/0006-8993(87)91667-2.

Abstract

The role of central delta-opioid receptors in the mediation of opioid reinforcement and endogenous reward processes was examined using a non-biased place-preference conditioning procedure. Intracerebroventricular (i.c.v.) administration of the selective delta-receptor agonist, [D-Pen2, D-Pen5]-enkephalin (DPDPE, 10.0-25.0 micrograms) produced a significant preference for the drug-associated place and a similar effect was observed following i.c.v. injections of morphine (10.0 micrograms). Administration of the delta-receptor antagonist, ICI 174,864, at doses (1.0-5.0 micrograms, i.c.v.) which had no aversive effects when tested alone, abolished the reinforcing properties of DPDPE. Such treatment did not, however, modify the effect of morphine. These findings demonstrate the involvement delta- as well as mu-receptors in the motivational properties of opioids and suggest that the activation of either receptor type is sufficient for the elicitation of appetitively reinforcing effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Appetitive Behavior / drug effects
  • Avoidance Learning / drug effects
  • Enkephalin, D-Penicillamine (2,5)-
  • Enkephalin, Leucine / administration & dosage
  • Enkephalin, Leucine / analogs & derivatives*
  • Enkephalin, Leucine / pharmacology
  • Enkephalins / administration & dosage
  • Enkephalins / pharmacology*
  • Injections, Intraventricular
  • Male
  • Morphine / administration & dosage
  • Morphine / pharmacology*
  • Motivation / physiology*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Opioid / drug effects
  • Receptors, Opioid / physiology*
  • Receptors, Opioid, delta
  • Reinforcement, Psychology*

Substances

  • Enkephalins
  • Receptors, Opioid
  • Receptors, Opioid, delta
  • Enkephalin, Leucine
  • Morphine
  • Enkephalin, D-Penicillamine (2,5)-
  • N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine